Effects of lamotrigine and topiramate on brain maturation and cognitive functions in offspring of pregnant rats - Preliminary study

Advances in Clinical and Experimental Medicine

Volumn 23, Issue 5, 2014, Pages 691-698

  Dag, Ersel ^a   Dag, Zeynep O ^a   Baydas, Giyasettin ^b   Tuzcu, Mehmet ^c   Yoldas, Tahir K ^d   Mungen, Bulent ^c   Bal, Ramazan ^c  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b BINGOL UNIVERSITY   (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

^d HARRAN UNIVERSITY   (Turkey)

Author keywords

Brain development; Cognitive functions; Lamotrigine; Topiramate

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; LAMOTRIGINE; NERVE CELL ADHESION MOLECULE; PROTEIN S100B; TOPIRAMATE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ASTROCYTE; BRAIN INJURY; BRAIN MATURATION; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DOWN REGULATION; FEMALE; HIPPOCAMPUS; LATENT PERIOD; MORRIS WATER MAZE TEST; NEWBORN; NONHUMAN; PERINATAL PERIOD; PROGENY; RAT; UPREGULATION; WESTERN BLOTTING;

ANIMALIA; RATTUS;

EID: 84931387682     PISSN: 18995276     EISSN: 24512680     Source Type: Journal    
DOI: 10.17219/acem/37219     Document Type: Conference Paper

References (35)

1. Pippenger CE: Pharmacology of Neural Tube Defects. Epilepsia 2003,44,24-32.
2. Ornoy A: The impact of intrauterine exposure versus postnatal environment in neurodevelopment toxicity: long term neurobehavioral studies in children at risk for developmental disorders. Toxicol Lett 2003,140, 171-181.
3. Park SP, Kwon SH: Cognitive effects of antiepileptic drugs. J Clin Neurol 2008, 4, 99-106.
4. Spear LP: Age at the time of testing reconsidered in neurobehavioral teratological research. In: Neurobehavioral Teratology. Ed.: Yanai J. Elsevier, New York 1984, 315-328.
5. Manent JB, Jorquera I, Franco V, Ben-Ari Y, Perucca E, Represa A: Antiepileptic drugs and brain maturation: fetal exposure to lamotrigine generates cortical malformations in rats. Epilepsy Res 2008, 78, 131-139.
6. Tzeng SF, H Cheng, YS Lee, JP Wu, BJ Hoffer, JS Kuo: Expression of neural cell adhesion molecule in spinal cords following a complete transaction. Life Sci 2001, 68, 1005-1012.
7. Cerutti SM, Chadi G: S100 immuno reactivity is increased in reactive astrocytes of the visual pathways following a mechanical lesion of the rat occipital cortex. Cell Biol Int 2000, 24, 35-49.
8. Hausmann R, Rieß R, Fieguth A, Betz P: Immunohistochemical investigations on the course of astroglial GFAP expression following human brain injury. Int J Legal Med 2000, 113, 70-75.
9. Herrmann M, Vos P, Wunderlich MT, Brujin CHMM, Lamers KJB: Release of glial tissue-specific proteins after acute stroke - A comparative analysis of serum concentrations of protein s-100 B and glial fibrillary acidic protein. Stroke 2000, 31, 2670-2677.
10. Stringer GL: Repeated seizures increase GFAP and vimentin in the hippocampus. Brain Res 1996, 717, 147-153.
11. Schäfer BW, CW Heizmann: The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996, 21, 134-140.
12. Morris RG, Garrud P, Rawlins JN, O'Keefe J: Place navigation impaired in rats with hippocampal lesions. Nature 1982, 297, 681-683.
13. Baydas G, Koz ST, Tuzcu M, Nedzvetsky VS: Melatonin prevents gestational hyperhomocysteinemia-associated alterations in neurobehavioral developments in rats. J Pineal Res 2008, 44, 181-188.
14. Schenk F, Morris RGM: Dissociation between components of spatial memory in rats after recovery from the effects of retrohippocampal lesion. Exp Brain Res 1985, 58, 11-28.
15. Vajda FJ, Graham J, Roten A, Lander CM, O'Brien TJ, Eadie M: Teratogenicity of the newer antiepileptic drugs - the Australian experience. J Clin Neurosci 2012,19, 57-59.
16. Holmes LB, Hernandez-Diaz S: Newer anticonvulsants: lamotrigine, topiramate and gabapentin. Birth Defects Res A Clin Mol Teratol 2012, 94, 599-606.
17. Hernández-Diaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, Holmes LB: North American AED Pregnancy Registry; North American AED Pregnancy Registry: Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012, 22, 1692-1699.
18. Ditte MN, Anders H: Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects. JAMA 2011, 305, 1996-2002.
19. Shi XY, Wang JW, Cui H, Li BM, Lei GF, Sun RP: Effects of antiepileptic drugs on m RNA levels of BDNF and NT-3 and cell neogenesis in the developing rat brain. Brain Dev 2010, 32, 229-235.
20. Chen J, Quan QY, Yang F, Wang Y, Wang JC, Zhao G, Jiang W: Effects of lamotrigine and topiramate on hippocampal neurogenesis in experimental temporal-lobe epilepsy. Brain Res 2010, 1313, 270-282.
21. Hajikhani R, Ahmadi A, Naderi N, Yaghoobi K, Shirazizand Z, Rezaee NM, Niknafs BN: Effect of phencycli-dine derivatives on anxiety-like behavior using an elevated-plus maze test in mice. Adv Clin Exp Med 2012, 21,3, 307-312.
22. Volpe JJ: Neuronal proliferation migration organization and myelination. In: Neurology of the newborn. WB Saunders, Philadelphia 2008, 5th ed., 82-90.
23. Schuck PF, Ferreira Gda C, Viegas CM, Tonin AM, Busanello EN, Pettenuzzo LF, Netto CA, Wajner M: Chronic early postnatal administration of elhylmalonic acid to rats causes behavioral deficit. Behav Brain Res 2009, 11,364-370.
24. Eng LF, Ghirnikar RS, Lee YL: Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000, 25, 1439-1451.
25. O'Callaghan JP, Sriram K: Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opin Drug Saf 2005, 4,433-442.
26. Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW: Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem 2004, 89,1092-1100.
27. Marenholz I, Heizmann CW, Fritz G: S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004, 322, 1111-1122.
28. Rothermundt M, Peters M, Prehn JH, Arolt V: S100B in brain damage and neurodegeneration. Microsc Res Tech 2003, 60,614-632.
29. Kleindienst A, Ross Bullock M: A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J Neurotrauma 2006, 23, 1185-1200.
30. Van Eldik LJ, Wainwright MS: The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restorative Neurol Neurosci 2003, 21, 97-108.
31. Seki T, Rutishauser U: Removal of polysialic acid-neural cell adhesion molecule induces aberrant mossy fiber innervation and ectopic synaptogenesis in the hippocampus. J Neurosci 1998, 18, 3757-3766.
32. Ono K, Tomasiewicz H, Magnuson T, Rutishauser U: N-CAM-mutation inhibits tangential neuronal migration and is phenocopied by enzymatic removal of polysialic acid. Neuron 1994, 13, 595-609.
33. Zhang H, Miller RH, Rutishauser U: Polysialic acid is required for optimal growth of axons on a neuronal substrate. J Neurosci 1992, 12, 3107-3114.
34. Edelman GM: Modulation of cell adhesion during induction, histogenesis, and perinatal development of the nervous system. Annu Rev Neurosci 1984, 7, 339-377.
35. Chuong CM, Edelman GM: Alterations in neural cell adhesion molecules during development of different regions of the nervous system. J Neurosci 1984, 4, 2354-2368.